TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2012

Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection.

Pamela Sears et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.